Cite Filings / CLOV / 0002052113-25-003014

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

CLOVER HEALTH INVESTMENTS, CORP. /DE Filed 2025-07-17 Acc 0002052113-25-003014

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-07-29 SCHEDULE 13G Statement of Beneficial Ownership
2025-07-24 4 CEO, Counterpart Health sold 209,797 shares at an average $3.30 ($692,968)
2025-07-22 4/A CEO of Home Care gave up 48,305 shares (to pay taxes)
2025-07-17 SCHEDULE 13G Statement of Beneficial Ownership
2025-07-10 4/A CEO, Counterpart Health sold 15,203 shares at $3.26 ($49,562)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…